Circulating non-coding RNAs (ncRNAs) regulate gene expression and thereby have the ability to initiate many pathological developments, including cancer. They are also stably present in diverse body fluids of the circulatory system and, as a result, ncRNAs have great potential to serve as biomarkers for cancers and other diseases. Although ncRNAs are easily sampled non-invasively through liquid biopsies, there is still a long way to go before they can be applied reproducibly and reliably in clinical diagnosis.Effective analytical techniques have been developed in order to detect microRNAs (miRNAs), a class of ncRNAs, in biospecimens and broaden their clinical utility. Isothermal amplification of miRNAs is a more economical alternative to RT-qPCR that can be more rapid, sensitive, specific, and simple. However, it is challenging to control the former’s background signal produced in the absence of target, severely hampering detection of low-abundance targets in complex biological samples. In the present work, exponential amplification reaction (EXPAR) was improved by chemically blocking the template with hexanediol and physically as well with cobalt oxyhydroxide (CoOOH) nanoflakes and T4 gene 32 (gp32) protein to suppress nonspecific template elongation and hence background signal. Synergism among the blocking agents greatly refined the EXPAR performance, which exhibited little to no cross-reactivity with non-targets and can detect as low as 10 aM of several miRNA targets, including miR-16, miR-21, and miR-122, using SYBR™ Gold. The CoOOH nanoflakes can also selectively adsorb single-stranded nucleic acids in complex media, such as serum, and function as a vehicle to transport them into a clean detection matrix for CoOOH-assisted EXPAR.
Exosomes are circulating nanovesicles that stabilize and relay miRNA during cell-cell communication. Although exosomal miRNAs are more reliable and sensitive biomarkers than circulating bare miRNAs, they are more challenging to detect due to their lower abundance and enclosure within extracellular vesicles. Herein, immunoprecipitation of exosomes and CoOOH-assisted EXPAR were utilized to fractionate raw healthy serum and screen the resulting exosome and exosome-free fractions for breast cancer miRNAs. It was found that miR-155 and miR-375 were detectable in the exosome-free fraction at aM and pM concentrations, respectively. For the purposes of this study, CoOOH-assisted EXPAR was further optimized to reach zM sensitivity, which underscores the power of CoOOH-assisted EXPAR in miRNA quantitation and its application in serum profiling of exosomal and non-exosomal miRNAs. Elucidating their relationship and diseased signatures will hone the use of two biomarker sources in diagnostic testing.